tiprankstipranks
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
PremiumPress ReleasesGreenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
2M ago
Greenwich LifeSciences’ Phase 3 trial protocol accepted by European regulators
PremiumThe Fly
Greenwich LifeSciences’ Phase 3 trial protocol accepted by European regulators
2M ago
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
PremiumPress Releases
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
2M ago
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024
PremiumPress ReleasesGreenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024
5M ago
Greenwich LifeSciences price target lowered to $38 from $78 at H.C. Wainwright
PremiumThe Fly
Greenwich LifeSciences price target lowered to $38 from $78 at H.C. Wainwright
1y ago
Greenwich LifeSciences provides year-end update
PremiumThe Fly
Greenwich LifeSciences provides year-end update
1y ago
Greenwich LifeSciences extends lock-up of directors, officers to end of 2023
PremiumThe FlyGreenwich LifeSciences extends lock-up of directors, officers to end of 2023
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100